Daily Cosmetic Research Analysis
Three studies stand out today in cosmetic and aesthetic medicine: a case-control study links higher follicular fluid concentrations of specific UV filters to diminished ovarian reserve; a randomized trial shows adhesive strips are non-inferior to subcuticular sutures for sternotomy scar cosmesis while saving time and cost; and a meta-analysis suggests labiaplasty may improve female sexual function, though underlying study quality is limited.
Summary
Three studies stand out today in cosmetic and aesthetic medicine: a case-control study links higher follicular fluid concentrations of specific UV filters to diminished ovarian reserve; a randomized trial shows adhesive strips are non-inferior to subcuticular sutures for sternotomy scar cosmesis while saving time and cost; and a meta-analysis suggests labiaplasty may improve female sexual function, though underlying study quality is limited.
Research Themes
- Cosmetic product safety and reproductive health (UV filters and ovarian reserve)
- Aesthetic surgical wound management and cost-effectiveness
- Female genital cosmetic surgery and sexual function outcomes
Selected Articles
1. Elevated follicular fluid concentrations of ultraviolet filters associated with diminished ovarian reserve: A case-control study.
In 102 women undergoing IVF-related procedures, higher follicular fluid levels of several UV filters—especially octyl methoxycinnamate—were strongly associated with diminished ovarian reserve, correlating negatively with AMH, AFC, and oocyte yield and positively with FSH. Adjusted models indicated a 3.8-fold increased DOR risk with elevated OMC, underscoring potential reproductive toxicity of certain cosmetic UV filters.
Impact: This study directly measures UV filters in the ovarian microenvironment and links them to ovarian reserve biomarkers and DOR risk, providing biologically plausible evidence that bridges cosmetic exposures and fertility.
Clinical Implications: Clinicians counseling women on fertility may consider discussing potential exposure to specific UV filters and encourage prudent selection of photoprotection strategies while awaiting confirmatory prospective data.
Key Findings
- Follicular fluid levels of OMC, UV-P, UV-328, and Ensulizole were significantly higher in women with diminished ovarian reserve.
- OMC concentrations correlated negatively with AMH, AFC, and oocytes retrieved, and positively with FSH.
- Elevated OMC was associated with a 3.8-fold increased odds of DOR after adjustment.
Methodological Strengths
- Targeted chemical analysis of 16 UV filters directly in follicular fluid
- Adjusted logistic regression and correlation analyses against established ovarian reserve biomarkers
Limitations
- Case-control design limits causal inference
- Single-population setting with moderate sample size may limit generalizability and residual confounding remains possible
Future Directions: Prospective cohort studies with longitudinal biomonitoring and mechanistic work on ovarian tissue exposure-response to specific UV filters are needed to clarify causality and safe exposure thresholds.
Ultraviolet filters (UVFs) are widely used in personal care products, their occurrence in the environment and potential detrimental effects on human health have raised significant concerns. This case-control study included 102 women-34 with diminished ovarian reserve (DOR) and 68 healthy controls-and aimed to investigate the association between UVF exposure and DOR. We collected and analyzed follicular fluid (FF) samples from women diagnosed with DOR and compared them to samples from a control group, measuring the concentrations of 16 different UVFs. Four individual compounds showed significantly higher concentrations in the DOR group: octyl methoxycinnamate (OMC), UV-P, UV-328, and Ensulizole. The cumulative concentration of ten UVFs with detection frequencies above 50 % was also markedly elevated in the DOR group (median ΣUVFs: 178.96 ng/mL vs. 23.93 ng/mL, p < 0.001). OMC exhibited the highest median concentration (170.81 ng/mL in DOR vs. 20.77 ng/mL in controls, p < 0.001), followed by UV-P, UV-328, and Ensulizole. Spearman analysis revealed significant negative correlations between OMC concentrations with ovarian reserve biomarkers such as anti-Müllerian hormone (AMH), antral follicle count (AFC), and the number of oocytes retrieved during ovarian stimulation cycles, while exhibiting a positive correlation with follicle-stimulating hormone (FSH) levels. Adjusted logistic regression models demonstrated that elevated OMC levels were associated with a 3.8-fold increased risk of DOR (95 % CI: 1.943-9.782, p < 0.001). These results highlight the urgent need for further investigation into the mechanisms by which UVFs affect ovarian reserve, as well as their potential long-term implications for fertility.
2. A Randomized Controlled Trial Comparison of Subcuticular Suture and Adhesive Strip for Cosmetic Outcome in Median Sternotomy Closure in Patient Undergoing Cardiac Surgery.
In a randomized trial of 106 evaluable cardiac surgery patients, adhesive strips achieved scar outcomes comparable to subcuticular sutures across VSS, MSS, and POSAS, with no increase in wound complications. Adhesive strips required far less application time (0.49 vs. 7.27 minutes) and reduced overall closure costs.
Impact: This pragmatic RCT suggests a simple, faster, and cheaper closure method can deliver equivalent scar cosmesis after median sternotomy, supporting practice change and resource savings.
Clinical Implications: Adhesive strips can be adopted as a first-line skin closure option after sternotomy when feasible, reducing operative time and costs without compromising cosmetic or safety outcomes.
Key Findings
- No significant differences in VSS, MSS, and POSAS between adhesive strips and subcuticular sutures through 6 months.
- Wound complications (infection, dehiscence) were similar between groups.
- Application time was dramatically shorter with adhesive strips (0.49 vs. 7.27 minutes), with lower total closure cost.
Methodological Strengths
- Randomized controlled design with complete follow-up
- Use of validated scar assessment scales (VSS, MSS, POSAS) and cost/time endpoints
Limitations
- Blinding is unlikely; cosmetic assessments could be subject to observer bias
- Follow-up limited to 6 months; long-term scar maturation not assessed
Future Directions: Multi-center trials with diverse skin types and longer follow-up could assess generalizability, patient-reported outcomes, and long-term scar quality.
BACKGROUND: The median sternotomy incision is a common approach in cardiac surgery, often leading to noticeable scar formation that can impact patients' quality of life. This study aims to compare outcomes between subcuticular suture and adhesive strip (Steri-stripTM, 3M HealthCare®) closure techniques for median sternotomy incisions in cardiac surgery patients. METHODS: In this prospective randomized controlled trial, 112 patients undergoing cardiac surgery (August 2020 to September 2021) were assigned to either the adhesive strip or subcuticular suture group. Wound assessments occurred on postoperative days 3, 7, and before discharge, monitoring for infection and dehiscence. Follow-ups at 1-2 weeks, 3 months, and 6 months used scar scales, including Vancouver Scar Scale (VSS), Manchester Scar Scale (MSS), and Patient and Observer Scar Assessment Scale (POSAS). RESULTS: Out of a total of 112 patients, 6 were excluded. All remaining patients were completely followed up. No significant differences were observed in VSS, MSS, POSAS outcomes, or wound complications during postoperative follow-ups. Adhesive strip closure took 0.49 minutes, significantly less than 7.27 minutes for subcuticular sutures (P < 0.001). Furthermore, the total cost of adhesive strips was lower than the subcuticular suture group. CONCLUSION: The adhesive strips application for skin closure of median sternotomy wounds was found to be non-inferior to subcuticular sutures in terms of clinical outcomes and postoperative wound complications. Additionally, this approach resulted in reduced operative time and proved to be cost-effective in hospital care. LEVEL OF EVIDENCE I: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
3. Female Sexual Function After Labiaplasty: A Systematic Review and Meta-analysis.
Across 11 studies (n=671), meta-analysis of FSFI-based outcomes showed an 18.8% improvement after labiaplasty, indicating potential short-term enhancement of sexual function. However, most included studies were weak to moderate quality with heterogeneous techniques and scales, limiting certainty.
Impact: Provides the most comprehensive quantitative synthesis to date on sexual function after labiaplasty, informing counseling and shared decision-making despite limitations.
Clinical Implications: Preoperative counseling should note probable short-term improvements in sexual function while emphasizing variability in techniques, study quality limitations, and the need for realistic expectations.
Key Findings
- Meta-analysis of six FSFI-based studies found an 18.8% improvement in sexual function after labiaplasty (P < 0.001).
- Of 11 included studies, 7 were rated weak and 4 moderate quality by EPHPP; none were strong.
- Heterogeneity in surgical techniques and outcome measures limits the strength of conclusions.
Methodological Strengths
- Comprehensive multi-database search with quantitative synthesis
- Use of standardized sexual function instrument (FSFI) in primary studies enabling pooling
Limitations
- Predominance of weak-quality, non-randomized studies with potential biases
- Short-term follow-up and heterogeneity in procedures and scales
Future Directions: Prospective, standardized, controlled studies with longer follow-up and consistent outcome measures are needed to confirm effects on sexual function and safety.
BACKGROUND: Labiaplasty often motivated by aesthetic and/or sexual and/or functional concerns, but with contradictory outcomes. The documentation regarding the safety and efficacy of these elective procedures is limited, primarily consisting of clinical case reports and retrospective studies. OBJECTIVES: This systematic review aimed to investigate the effect of labiaplasty on sexual function. METHODS: An electronic search in PubMed, Web of Science, Scopus, PsycINFO, Embase, the Cochrane Library, and ClinicalTrials.gov from 2000 to 2024 was performed. Articles that focused on labia minora surgeries performed for cosmetic, and/or sexual, and/or psychological, and/or functional reasons (excluding medical indications like reversing female genital cutting, straddle injuries, or other genital injuries) were considered. Additionally, selected articles were required to evaluate post-operative sexual function using a quantitative tool. A meta-analysis using a random-effects model was used to derive weighted pooled estimates of sexual function after labiaplasty. RESULTS: The authors identified a total of 11 articles (with 671 participants) that evaluated sexual function after labiaplasty. Based on the Effective Public Health Practice Project's Quality Assessment Tool for Quantitative Studies (EPHPP), out of the 11 articles reviewed, 7 were categorized as weak, 4 as moderate, and none as strong. Of the studies reviewed, 6 studies used Female Sexual Function Index (FSFI). A meta-analysis of these six studies (with eight groups) revealed that labiaplasty was associated with an 18.8% improvement in the FSFI score, P < 0.001. CONCLUSION: Labiaplasty appears to have a positive impact on women's sexual function, at least in the short term. However, inconsistencies in procedures, study design, and scales have limited this conclusion. In pre-surgery counseling, patients must be informed about the limited knowledge on labiaplasty's impact on sexual function. LEVEL OF EVIDENCE III: Evidence obtained from well-designed analytic studies. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .